Maria Elisabet Wrethag
Direktor/Vorstandsmitglied bei Archaea Pharma AB
Profil
Ms. Maria Elisabet Wrethag is Chief Marketing Officer & Head-Investor Relations at SyntheticMR AB.
She is on the Board of Directors at Accelerator Nordic AB and Archaea Pharma AB.
Ms. Wrethag also served on the board at SPAGO Nanomedical AB and AddBIO AB.
She received her undergraduate degree from the University of Uppsala and a graduate degree from the University of Uppsala.
Aktive Positionen von Maria Elisabet Wrethag
| Unternehmen | Position | Beginn |
|---|---|---|
| Archaea Pharma AB | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Maria Elisabet Wrethag
| Unternehmen | Position | Ende |
|---|---|---|
| SPAGO NANOMEDICAL AB | Direktor/Vorstandsmitglied | - |
AddBIO AB
 AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Direktor/Vorstandsmitglied | - |
| SYNTHETICMR AB | Direktor/Vorstandsmitglied | 01.10.2013 |
Accelerator Nordic AB
 Accelerator Nordic AB Pharmaceuticals: MajorHealth Technology Accelator Nordic AB, a holding company, is engaged in the field of life science. It focuses on the development of image software and medical nanotechnology. It operates through its subsidiaries SPAGO Imaging AB, Synthethic MR AB, and PledPharma. The company was founded in March 1993 and is headquartered in Stockholm, Sweden. | Vorstandsvorsitzender | - |
Ausbildung von Maria Elisabet Wrethag
| University of Uppsala | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SYNTHETICMR AB | Health Technology |
| SPAGO NANOMEDICAL AB | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Accelerator Nordic AB
Accelerator Nordic AB Pharmaceuticals: MajorHealth Technology Accelator Nordic AB, a holding company, is engaged in the field of life science. It focuses on the development of image software and medical nanotechnology. It operates through its subsidiaries SPAGO Imaging AB, Synthethic MR AB, and PledPharma. The company was founded in March 1993 and is headquartered in Stockholm, Sweden. | Health Technology |
AddBIO AB
AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Health Technology |
| Archaea Pharma AB |
